The study provides compelling evidence that diets with a high GI or a high GL will increase the risk of type 2 diabetes and heart disease. References and…
A recent study demonstrates that in patients with very mild or well-controlled asthma, regular treatment with low dose ICS leads to significantly better day-to-day lung function. References and…
The FDA has approved the Phase II trial for the evaluation of the Drug-Eluting Bead delivering irinotecan in patients with hepatic colo-rectal metastases. References and Resources FDA.gov Sponsored…
Effective rheumatoid arthritis treatment may reduce the risk of heart attacks, strokes, and cardiovascular disease, according to an international study. References and Resources Naranjo A, Sokka T, Descalzo…
The FDA has approved an ophthalmic solution that combines brimonidine and timolol or Combigan for reduction of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. References…
A blood test for mood disorders that enables better diagnosis and treatment may be feasible by extracting RNA to measure the expression of various genes identified as biomarkers…
Howard Simon, MD, Director, Newly Invasive and Bariatric Surgery, State University Hospital Syracuse, discusses the complications associated with bariatric surgery. References and Resources Fernández-Esparrach G, Bordas JM, Pellisé…
John Goodman, president of J O Goodman & Associates, Inc. – Heart And Vascular Business Consultants, discusses the imbalance in physician pay. jogoodmanassociates.comRelated Videos on The Doctor’s Channel:…
Erythropoiesis-stimulating agent administration to patients with cancer is associated with increased risks of VTE and mortality. References and Resources Bennett C., Silver S., Djulbegovic B., et al. Venous…
The FDA has notified healthcare professionals of reports of clinically significant liver injury, including markedly elevated serum hepatic enzymes and elevated total bilirubin, occurring as early as six…
